The investment is expected to help diverse populations and, as an extension, improve outcomes across all populations affected by diseases, according to an Aug. 12 news release.
The death of George Floyd and pandemic further exposed persistent health disparities that leave under-resourced and minority communities at greater risk of poor health outcomes, according to Bristol Myers Squibb. The company has spent the past months developing an approach that reflects broad input and is consistent with its values.
The pharmaceutical company said it will focus efforts on addressing health disparities, increasing clinical trial diversity, expanding its supplier diversity program, increasing workforce diversity and expanding its U.S. Employee Giving Program.
More articles on pharmacy:
Kamala Harris’ stance on Big Pharma: 5 things to know
Louisiana pharmacy CEO pleads guilty to $50M reimbursement fraud
Specialty drug price caps drastically reduce out-of-pocket costs without increasing health plan spending
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
